At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 198 enrolled
Drug / intervention
hylan G-F 20 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
American Orthopaedic Society for Sports Medicine·interventional·Posted Mar 20, 2012·Updated Apr 2, 2014
In Brief
A Phase 4 clinical trial evaluating hylan G-F 20 and 1% sodium hyaluronate for Osteoarthritis, Knee. Completed, enrolled 198 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate whether the investigators can develop a computer algorithm to predict which individual patients will respond to injections of hyaluronic acid (HA) products for knee osteoarthritis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee
CountriesUnited States
CollaboratorsUnited States Naval Medical Center, Portsmouth
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2008
First PostedMar 2012
Primary CompletionDec 2012
TodayJul 2026
First PostedMar 20, 2012
Enrollment StartOct 1, 2008
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 14.3 years ago
Interventions
hylan G-F 20device
Three 2 cc injections at weekly intervals
1% sodium hyaluronatedevice
Three 2 cc injections at weekly intervals